Rare diseases
Investigational molecules
Locations
Im Neuenheimer Feld 517, Neuenheim, 69120 Heidelberg, Germany
Rheacell GmbH & Co. KG focuses on clinical research in epidermolysis bullosa, with attention to both recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa. The sponsor’s work in this area is centered on severe skin fragility, chronic wound burden, and the need for therapies that support wound improvement in affected patients.
Clinical activity in this field includes both adult and very young patients, reflecting interest in difficult-to-treat inherited skin disease across age groups.
Rheacell GmbH & Co. KG runs clinical trials in conditions such as Skin ulcer, Epidermolysis bullosa, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaAustriaGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
